With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14% ...
Yes, you can get your flu and COVID-19 shots at the same time. Don’t call them boosters — they’re not just another dose of ...
The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
Novavax has struggled to keep pace with rival vaccine makers Moderna and Pfizer, which reported more than $3 billion in ...
The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...
Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...
A person enrolled in a clinical trial receives the COVID vaccine. Employers' vaccine mandates came under scrutiny during the ...
Novavax had been hoping to find a sizable sales opportunity by advancing a protein-based alternative to the messenger RNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback